Oxaliplatin and Pepcid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Oxaliplatin (oxaliplatin) and Pepcid (famotidine). Common drug interactions include abdominal distension among females and paraneoplastic syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Oxaliplatin and Pepcid. It is created by eHealthMe based on reports of 122 people who take the same drugs from the FDA, and is updated regularly.
What is Oxaliplatin?
Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.
What is Pepcid?
Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.
122 people who take Oxaliplatin and Pepcid together, and have interactions are studied.
What are the common drug interactions of Oxaliplatin and Pepcid, by gender? *
What are the common drug interactions of Oxaliplatin and Pepcid, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Oxaliplatin and Pepcid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Oxaliplatin (72,058 reports)
- Pepcid (55,774 reports)
Browse all drug interactions of Oxaliplatin and Pepcid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Oxaliplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pepcid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Oxaliplatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pepcid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
- Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .
- Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
- Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on oxaliplatin and famotidine (the active ingredients of Oxaliplatin and Pepcid, respectively), and Oxaliplatin and Pepcid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Advair Hfa and Clopidogrel - 9 seconds ago
- Could Vitamin B cause Hypoglycaemia Aggravated? - 19 seconds ago
- Could Vitamin B cause Thrombosis? - 20 seconds ago
- Could Sulfadiazine cause Malaise? - 25 seconds ago
- Could Admelog cause Abdominal Pain? - 25 seconds ago
- Could Docetaxel cause Blood Alkaline Phosphatase Increased? - 29 seconds ago
- Drug interactions of Sulfamethoxazole And Trimethoprim and Kevzara - 51 seconds ago
- Pemphigus and Weight Decreased - a minute ago
- Could Ivermectin cause Seizures? - a minute ago
- Could Paracetamol cause Type 2 Diabetes? - a minute ago